Evaluation of COVID-19 and Influenza-like Illness Surveillance Case Definitions in a Prospective Cohort of Healthcare Personnel in Peru
Clinical Infectious Diseases · 2025
DOI: 10.1093/cid/ciaf340 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Infectious Diseases, 2025. Verfasst von Denisse Vega Ocasio und 19 weiteren Autor:innen. Beteiligte Einrichtung: Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA. Hauptthemen laut MEDLINE: COVID-19, Influenza, Human, Health Personnel. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Intramural CDC HHS, US Naval Medical Research Unit SOUTH, US Centers for Disease Control and Prevention.
Abstract (Originalsprache)
Background
Public health agencies employ case definitions for influenza virus and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections to optimize surveillance, monitor disease trends, and inform decision-making, particularly in limited resource settings.
Methods
Using a prospective healthcare personnel cohort in two hospitals in Lima, Peru (July 2022–June 2023), we compared and evaluated the performance of three symptom profiles of three common surveillance case definitions to identify influenza and SARS-CoV-2 infections: influenza-like illness, coronavirus disease 2019–like illness (CLI), and acute respiratory infection. Participants with an acute respiratory illness reported symptom progression twice weekly. Participants self-collected nasal swabs for SARS-CoV-2 and influenza reverse transcription real-time polymerase chain reaction testing. Sensitivity, specificity, and positive and negative predictive values of each case definition were evaluated.
Results
Of 1623 participants enrolled, 1450 illness episodes were reported; 92 (6%) were positive for influenza, 350 (24%) for SARS-CoV-2, and 3 (0.2%) were positive for both. For the four influenza-like illness case definitions evaluated, all yielded low sensitivity for detection of influenza (points estimate range, 23%–35%) and SARS-COV-2 (range, 21%–29%), but high specificity (83%–90% and 86%–92%, respectively). In contrast, the acute respiratory infection and coronavirus disease 2019–like illness definitions both yielded high sensitivity (83%–100%) and low specificity (2%–41%) for detection of both influenza and SARS-CoV-2.
Conclusions
The performance of case definitions was similar for influenza and SARS-CoV-2 supporting the use of the same definitions by surveillance networks. The substantial differences in sensitivity and specificity across the case definitions necessitate surveillance objectives and cost considerations in selecting a case definition fit for purpose.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
- Coronavirus and Other Respiratory Viruses Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
- Clinical Trials Unit, U.S. Naval Medical Research Unit SOUTH (NAMRU SOUTH), Lima, Peru.
- Division of Healthcare Quality and Promotion, National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
- Vysnova Partners, Inc. (assigned to Clinical Trials Unit, NAMRU SOUTH), Alexandria, Virginia, USA.
- Infectious Diseases and Tropical Medicine Department, Cayetano Heredia Hospital, Lima, Peru.
ORCID-Profile: Eva Leidman, Perrine Marcenac, Joseph Daniel Carreon, Chelsea Iwamoto, Matthew Westercamp, Michael Prouty, Joan Neyra, Eduardo Matos, Ashley Fowlkes
Förderung
- Intramural CDC HHS
- US Naval Medical Research Unit SOUTH
- US Centers for Disease Control and Prevention
- CDC Interagency
Zitieren
APA
Vega Ocasio, D., Patel, N. N., Leidman, E., Marcenac, P., Carreon, J. D., Iwamoto, C., Soto, G. M., Westercamp, M., Bollinger, S., Romero, C., Silva, M., Prouty, M., Lessa, F. C., Neyra, J., Ponce, D., Castillo, R., Llanos-Cuentas, A., Matos, E., Smith, R. M., & Fowlkes, A. (2025). Evaluation of COVID-19 and Influenza-like Illness Surveillance Case Definitions in a Prospective Cohort of Healthcare Personnel in Peru. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciaf340
Vancouver
Vega Ocasio D, Patel NN, Leidman E, Marcenac P, Carreon JD, Iwamoto C, et al. Evaluation of COVID-19 and Influenza-like Illness Surveillance Case Definitions in a Prospective Cohort of Healthcare Personnel in Peru. Clinical Infectious Diseases. 2025. doi:10.1093/cid/ciaf340
BibTeX
@article{VegaOcasio2025,
author = {Vega Ocasio, Denisse and Patel, Neha N and Leidman, Eva and Marcenac, Perrine and Carreon, Joseph Daniel and Iwamoto, Chelsea and Soto, Giselle M and Westercamp, Matthew and Bollinger, Susan and Romero, Candice and Silva, Maria and Prouty, Michael and Lessa, Fernanda C and Neyra, Joan and Ponce, Diana and Castillo, Roger and Llanos-Cuentas, Alejandro and Matos, Eduardo and Smith, Rachel M and Fowlkes, Ashley},
title = {Evaluation of COVID-19 and Influenza-like Illness Surveillance Case Definitions in a Prospective Cohort of Healthcare Personnel in Peru},
journal = {Clinical Infectious Diseases},
year = {2025},
doi = {10.1093/cid/ciaf340}
}
EUVIMED